Drug Price Transparency
Drug Price Transparency organizes records from CMS data API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
| Record | Record Date | Vuga Group | Change Status | Recency Days | Public Significance Score |
|---|---|---|---|---|---|
| Kimyrsa | 01/01/2024 | Oritavancin Diphosphate | increased | 972.23 | 100 |
| Kineret | 01/01/2024 | Anakinra | increased | 972.23 | 100 |
| Kineret | 01/01/2024 | Anakinra | increased | 972.23 | 100 |
| Kinrix | 01/01/2024 | Diph,Pertus(Acel),Tet,Polio/PF | increased | 972.23 | 100 |
| Kinrix | 01/01/2024 | Diph,Pertus(Acel),Tet,Polio/PF | increased | 972.23 | 100 |
| Kisqali Femara Co-Pack | 01/01/2024 | Ribociclib Succinate/Letrozole | increased | 972.23 | 100 |
| Kisqali Femara Co-Pack | 01/01/2024 | Ribociclib Succinate/Letrozole | increased | 972.23 | 100 |
| Kisqali | 01/01/2024 | Ribociclib Succinate | increased | 972.23 | 100 |
| Kisqali | 01/01/2024 | Ribociclib Succinate | increased | 972.23 | 100 |
| Klisyri | 01/01/2024 | Tirbanibulin | increased | 972.23 | 100 |
| Klisyri | 01/01/2024 | Tirbanibulin | increased | 972.23 | 100 |
| Korlym | 01/01/2024 | Mifepristone | increased | 972.23 | 100 |
| Korlym | 01/01/2024 | Mifepristone | increased | 972.23 | 100 |
| Koselugo | 01/01/2024 | Selumetinib Sulfate | increased | 972.23 | 100 |
| Koselugo | 01/01/2024 | Selumetinib Sulfate | increased | 972.23 | 100 |
| Krazati | 01/01/2024 | Adagrasib | increased | 972.23 | 100 |
| Krazati | 01/01/2024 | Adagrasib | increased | 972.23 | 100 |
| Krystexxa | 01/01/2024 | PEGloticase | increased | 972.23 | 100 |
| Krystexxa | 01/01/2024 | PEGloticase | increased | 972.23 | 100 |
| Kuvan | 01/01/2024 | Sapropterin Dihydrochloride | increased | 972.23 | 100 |
| Kuvan | 01/01/2024 | Sapropterin Dihydrochloride | increased | 972.23 | 100 |
| Kyleena | 01/01/2024 | Levonorgestrel | increased | 972.23 | 100 |
| Kyleena | 01/01/2024 | Levonorgestrel | increased | 972.23 | 100 |
| Kyprolis | 01/01/2024 | Carfilzomib | increased | 972.23 | 100 |
| Kyprolis | 01/01/2024 | Carfilzomib | increased | 972.23 | 100 |
| Lanreotide Acetate | 01/01/2024 | Lanreotide Acetate | increased | 972.23 | 100 |
| Lanreotide Acetate | 01/01/2024 | Lanreotide Acetate | increased | 972.23 | 100 |
| Lanreotide Acetate | 01/01/2024 | Lanreotide Acetate | increased | 972.23 | 100 |
| Lazcluze | 01/01/2024 | Lazertinib Mesylate | increased | 972.23 | 100 |
| Lazcluze | 01/01/2024 | Lazertinib Mesylate | increased | 972.23 | 100 |
| Ledipasvir-Sofosbuvir | 01/01/2024 | Ledipasvir/Sofosbuvir | increased | 972.23 | 100 |
| Ledipasvir-Sofosbuvir | 01/01/2024 | Ledipasvir/Sofosbuvir | increased | 972.23 | 100 |
| Lenalidomide | 01/01/2024 | Lenalidomide | increased | 972.23 | 100 |
| Lenalidomide | 01/01/2024 | Lenalidomide | increased | 972.23 | 100 |
| Lenalidomide | 01/01/2024 | Lenalidomide | increased | 972.23 | 100 |
| Lenalidomide | 01/01/2024 | Lenalidomide | increased | 972.23 | 100 |
| Lenalidomide | 01/01/2024 | Lenalidomide | increased | 972.23 | 100 |
| Lenalidomide | 01/01/2024 | Lenalidomide | increased | 972.23 | 100 |
| Lenalidomide | 01/01/2024 | Lenalidomide | increased | 972.23 | 100 |
| Lenalidomide | 01/01/2024 | Lenalidomide | increased | 972.23 | 100 |
| Lenalidomide | 01/01/2024 | Lenalidomide | increased | 972.23 | 100 |
| Lenalidomide | 01/01/2024 | Lenalidomide | increased | 972.23 | 100 |
| Lenalidomide | 01/01/2024 | Lenalidomide | increased | 972.23 | 100 |
| Lenvima | 01/01/2024 | Lenvatinib Mesylate | increased | 972.23 | 100 |
| Lenvima | 01/01/2024 | Lenvatinib Mesylate | increased | 972.23 | 100 |
| Leqembi | 01/01/2024 | Lecanemab-Irmb | increased | 972.23 | 100 |
| Leqembi | 01/01/2024 | Lecanemab-Irmb | increased | 972.23 | 100 |
| Leqvio | 01/01/2024 | Inclisiran Sodium | increased | 972.23 | 100 |
| Leqvio | 01/01/2024 | Inclisiran Sodium | increased | 972.23 | 100 |
| Letairis | 01/01/2024 | Ambrisentan | increased | 972.23 | 100 |